ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A retrospective cohort study of response and survival in pediatric patients with relapsed and refractory acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LLy) treated with contemporary salvage therapy
Protocol ID
T2018-001
Disease (Sub Disease)
Leukaemia (ALL)
Lymphoma (LLy)
Diagnosis Stage
Relapsed/refractory
Location
NSW, VIC
Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Trial Status
Open
Sites
The Children's Hospital at Westmead
Royal Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 21 years
Back to Registry
Study Title A retrospective cohort study of response and survival in pediatric patients with relapsed and refractory acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LLy) treated with contemporary salvage therapy
Protocol ID T2018-001
Disease (Sub Disease) Leukaemia (ALL)
Lymphoma (LLy)
Diagnosis Stage Relapsed/refractory
Location NSW / VIC
Sponsor Therapeutic Advances in Childhood Leukemia Consortium
Trial Status Open
Trial Open Date 01/01/2022
Sites The Children's Hospital at Westmead/ Royal Children's Hospital
Study Type Observational
Phase Not applicable
Age Eligibility up to 21 years

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.